A Phase II study to confirm the effectiveness of TS-1 plus docetaxel for aged patients with advanced and/or metastatic gastric cancer (OGSG 0902) - A Phase II study to confirm the effectiveness of TS-1 plus docetaxel for aged patients with advanced and/or metastatic gastric cancer (OGSG 0902)

Osaka Gastrointestinal cancer chemotherapy Study Group (OGSG)0 个研究点目标入组 31 人开始时间: 2009年11月19日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients with active double cancers 2) Any other serious illness or medical condition(s) including ileus, intestinal obstruction, uncontrolled DM, interstitial pneumonia or pulmonary fibrosis, heart failure, renal failure, liver failure, etc. 3) Patients with ascites and/or pleural fluid 4) Patients with any symptoms due to metastases to the central nervous system 5) Patients with any fresh bleeding from digestive tract 6) with severe ischemic cardiac diseases or arythmia which needs treatments 7) Patients with interstitial pneumonia or pulmonary fibrosis diagnosed by chest X ray and/or CT 8) History of serious drug hypersensitivity due to 5-FU, Docetaxel or Polysolbate 80 9) Patients with severe dysfunction of kidney, bone marrow and/or liver 10) Patients who need flucitosine, fenitoin or walfarin 11) Patients with untreated edema 12) Any other patient whom the physician in charge of the study judges to be unsuitable.

发起方

Osaka Gastrointestinal cancer chemotherapy Study Group (OGSG)